Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celbius is a UK-based biotechnology company specializing in the application of power ultrasound to bioprocessing and chemical synthesis, a field known as sonoprocessing. The company's proprietary technology enhances the efficiency of fermentation, enzymatic transformations, and the extraction of high-value compounds from natural sources by improving mass transfer and reaction rates. Celbius provides specialized ultrasonic equipment and consultancy services to help pharmaceutical and industrial biotech companies optimize their production workflows. Their solutions are designed to reduce processing times, increase product yields, and lower energy consumption in the manufacture of high-value bio-products. The company actively collaborates on research projects to advance sustainable and cost-effective manufacturing methods in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Celbius.